A Trial of Suprascapular Nerve Block for shoulder Pain in Motor Neuron Disease.

Status

Completed

Phases

Unknown

Study type

Interventional

Source

ANZCTR

Registry ID

ACTRN12619000353190

Enrollment

Registered

2019-03-06

Start date

2008-05-02

Completion date

2018-07-15

Last updated

2019-07-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Brief summary

This study aimed to quantify the prevalence of shoulder pain in people with MND and assess the efficacy of suprascapular nerve block (SSNB) for its management.

Interventions

Suprascapular nerve block 20 mg depomedrol plus 10 mls of 0.5% bupivacaine as a single one off injection intramuscularly

Study design

Allocation

Non-randomised trial

Primary purpose

Treatment

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

Symptomatic shoulder pain in patents with motor neuron disease

Exclusion criteria

Allergy to corticosteroid or local anaesthetic

Outcome results